DICOPAC KIT
LOE ApproachingNDAN/AN/A
Approved
Jun 1974
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 10h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DICOPAC KIT is a diagnostic imaging kit developed by GE HealthCare and approved in 1974, representing a legacy diagnostic product in the radiopharmaceutical space. The specific indication and mechanism of action are not publicly detailed in available records, but the kit format suggests a radiopharmaceutical diagnostic agent. This product serves as a foundational diagnostic tool in GE HealthCare's imaging portfolio.
LOE Approaching
As a 50-year-old diagnostic product approaching loss of exclusivity, commercial teams are likely right-sized or contracting; limited career expansion opportunities remain on this mature brand.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
DICOPAC KIT offers limited career opportunities given its mature lifecycle and approaching loss of exclusivity. Roles remain primarily in legacy brand management, compliance, and customer support rather than growth-oriented positions.
Product ManagerField Sales Representative
Worked on DICOPAC KIT at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.